Last updated: July 11, 2026

Application No. 19/443,731

Untitled Application

Unknown

Filed

Priority

Mar 28, 2019 — provisional 62/825,252 +2 more

Examiner

SULLIVAN, DENNIS JOHN

Art Unit

Tech Center

Janssen Biotech, Inc.

Assignee

Janssen Pharmaceuticals Inc.

OA Round

1 (Non-Final)

This examiner grants 61% of cases after interview

— +47.4% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 108 resolved cases, 2023–2026

Examiner Intelligence

SULLIVAN, DENNIS JOHN View full profile →

Grants 61% of resolved cases

Career Allowance Rate

66 granted / 108 resolved

+1.1% vs TC avg

Strong +47% interview lift

Without

With

+47.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 8m

Avg Prosecution

47 currently pending

Career history

157

Total Applications

across all art units

Statute-Specific Performance

§101

1.7%

-38.3% vs TC avg

§103

49.2%

+9.2% vs TC avg

§102

0.9%

-39.1% vs TC avg

§112

11.9%

-28.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 108 resolved cases

Prosecution Timeline

Apr 22, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/866,587

Patent 12674796

SINGLE CELL PATHOLOGY ANALYSIS OF TUMOUR SAMPLES

3y 11m to grant Granted Jul 07, 2026

17/627,167

Patent 12668621

COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUBERCULOSIS

4y 5m to grant Granted Jun 30, 2026

17/639,765

Patent 12662689

NOVEL PROMOTER AND METHOD FOR PRODUCING DESIRED SUBSTANCE USING SAME

4y 3m to grant Granted Jun 23, 2026

17/625,520

Patent 12655203

Neutralizing Antibody for Tooth Regeneration Treatment Targeting USAG-1 Molecule

4y 4m to grant Granted Jun 16, 2026

17/904,459

Patent 12649797

HUMAN 4-1BB AGONIST ANTIBODIES AND METHODS OF USE THEREOF

3y 9m to grant Granted Jun 09, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

61%

Grant Probability

99%

With Interview (+47.4%)

3y 8m

Median Time to Grant

Low

PTA Risk

Based on 108 resolved cases by this examiner. Grant probability derived from career allowance rate.